Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Definitive Healthcare Corp.
DH
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $84.4M
$0.78
▼ -2.53%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$0.62 - $4.70
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 80.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Comprehensive proprietary healthcare data covering 16 functional intelligence modules
- Deep integration across the healthcare ecosystem with access to provider, payer, and commercial organization data
- Established customer relationships with major biopharmaceutical, medical device, and healthcare IT companies
- Scalable SaaS platform with high switching costs and recurring revenue model
- Specialized expertise in healthcare market dynamics and provider intelligence
Bear Case
1 risk
- Average volatility.
Growth
Turning profitable
Increasing demand for healthcare commercial intelligence from biopharmaceutical and medical device companies
Value
Deep value opportunity - significant discount to Healthcare IT & Services peers
Momentum
Falling
-25.9% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying DH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 30, 2026
MAY 7, 2026
Reported EPS of $0.06 vs $0.03 consensus (+100.0% surprise). Revenue of $55.9M vs $55.0M expected (+1.6%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+100.0%
Next: Apr 30, 2026
Revenue trend · last 8Q
—
—
-6%
-7%
-5%
-4%
-1%
-6%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$63.7M
$62.7M
$62.3M
$59.2M
$60.8M
$60.0M
$61.5M
$55.9M
Margins · last 8Q
Gross
—
Operating
—
Profit
-247.8%
Wall Street consensus
4 analysts · 25% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
25%
Hold
50%
Sell
25%
Median Price Target
$1.10
▲ +41.1% vs $0.78
Latest: Bank of America · Jun 29, 2026
1 analyst covering